These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure. Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770 [TBL] [Abstract][Full Text] [Related]
6. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT). Taniguchi Y; Sasaki S Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068 [TBL] [Abstract][Full Text] [Related]
7. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target. Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156 [TBL] [Abstract][Full Text] [Related]
8. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence. Simon P; Cannata F; Concordet JP; Giovannangeli C Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344 [TBL] [Abstract][Full Text] [Related]
9. Targeted genome modification via triple helix formation. Kalish JM; Glazer PM Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134 [TBL] [Abstract][Full Text] [Related]
12. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133 [TBL] [Abstract][Full Text] [Related]
13. Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Sedelnikova OA; Karamychev VN; Panyutin IG; Neumann RD Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):43-9. PubMed ID: 12022689 [TBL] [Abstract][Full Text] [Related]
14. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides. Graham MK; Brown TR; Miller PS Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916 [TBL] [Abstract][Full Text] [Related]
15. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289 [TBL] [Abstract][Full Text] [Related]
16. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities. Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028 [TBL] [Abstract][Full Text] [Related]
17. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides. Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903 [TBL] [Abstract][Full Text] [Related]
18. The development of bioactive triple helix-forming oligonucleotides. Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131 [TBL] [Abstract][Full Text] [Related]
19. Importance of clustered 2'-O-(2-aminoethyl) residues for the gene targeting activity of triple helix-forming oligonucleotides. Puri N; Majumdar A; Cuenoud B; Miller PS; Seidman MM Biochemistry; 2004 Feb; 43(5):1343-51. PubMed ID: 14756571 [TBL] [Abstract][Full Text] [Related]
20. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Luo Z; Macris MA; Faruqi AF; Glazer PM Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9003-8. PubMed ID: 10900269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]